2seventy Bio Stock Current Liabilities
| TSVT Stock | USD 4.95 2.15 76.79% |
2Seventy Bio fundamentals help investors to digest information that contributes to 2Seventy Bio's financial success or failures. It also enables traders to predict the movement of 2Seventy Stock. The fundamental analysis module provides a way to measure 2Seventy Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 2Seventy Bio stock.
2Seventy |
2Seventy Bio Company Current Liabilities Analysis
2Seventy Bio's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, 2Seventy Bio has a Current Liabilities of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
2Seventy Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 2Seventy Bio's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 2Seventy Bio could also be used in its relative valuation, which is a method of valuing 2Seventy Bio by comparing valuation metrics of similar companies.2Seventy Bio is currently under evaluation in current liabilities category among its peers.
2Seventy Fundamentals
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (2.07) % | ||||
| Operating Margin | (0.99) % | ||||
| Current Valuation | 313.93 M | ||||
| Shares Outstanding | 52.3 M | ||||
| Shares Owned By Insiders | 6.58 % | ||||
| Shares Owned By Institutions | 88.36 % | ||||
| Number Of Shares Shorted | 5.14 M | ||||
| Price To Book | 1.13 X | ||||
| Price To Sales | 5.67 X | ||||
| Revenue | 100.39 M | ||||
| Gross Profit | (90.73 M) | ||||
| EBITDA | (206.42 M) | ||||
| Net Income | (217.57 M) | ||||
| Cash And Equivalents | 357.93 M | ||||
| Cash Per Share | 9.45 X | ||||
| Total Debt | 256.67 M | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 3.88 X | ||||
| Book Value Per Share | 4.43 X | ||||
| Cash Flow From Operations | (166.86 M) | ||||
| Short Ratio | 17.13 X | ||||
| Earnings Per Share | (1.83) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 274 | ||||
| Beta | 1.74 | ||||
| Market Capitalization | 258.88 M | ||||
| Total Asset | 565.43 M | ||||
| Retained Earnings | (511.22 M) | ||||
| Working Capital | 177.99 M | ||||
| Net Asset | 565.43 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.